SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that VIA management will present at three upcoming investor conferences.



    The presentation details are as follows:

    Rodman & Renshaw Annual Global Investment Conference
    Wednesday, November 12, 2008, 10:20 a.m. ET
    New York, NY

    Lazard Capital Markets Healthcare Conference
    Wednesday, November 19, 2008, 11:30 a.m. ET
    New York, NY

    20th Annual Piper Jaffray Health Care Conference
    Tuesday, December 2, 2008, 4:00 p.m. ET
    New York, NY

Interested parties may access live audio webcasts of the presentations from the investor section of the VIA website, http://www.viapharmaceuticals.com. Replays of the presentations will be archived on the VIA website for at least one week following each presentation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.

SOURCE VIA Pharmaceuticals, Inc.